Sequential therapy versus standard triple therapy for Helicobacter pylori eradication in children: any advantage in clarithromycin-resistant strains?

被引:23
|
作者
Kutluk, Gunsel [1 ]
Tutar, Engin [1 ]
Bayrak, Aykut [1 ]
Volkan, Burcu [1 ]
Akyon, Yakut [3 ]
Celikel, Cigdem [2 ]
Ertem, Deniz [1 ]
机构
[1] Marmara Univ Sch Med, Div Pediat Gastroenterol Hepatol & Nutr, TR-34854 Istanbul, Turkey
[2] Marmara Univ Sch Med, Dept Pathol, TR-34854 Istanbul, Turkey
[3] Hacettepe Univ Sch Med, Dept Microbiol, Ankara, Turkey
关键词
antibiotic resistance; children; Helicobacter pylori; sequential; standard; treatment; ANTIBIOTIC-RESISTANCE; RANDOMIZED-TRIAL; CONSENSUS REPORT; INFECTION; METAANALYSIS; MANAGEMENT; GENOTYPES; REGIMEN; SPECIMENS; TRENDS;
D O I
10.1097/MEG.0000000000000190
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Objective There has been a marked decrease in the eradication rates of Helicobacter pylori infection with standard triple therapy worldwide. Hence, sequential therapy has gained attention as a promising treatment during the last few years. This study was carried out to compare the efficacy of sequential versus standard triple therapy in the context of clarithromycin (CLA) resistance. Materials and methods In this study, children between 3 and 18 years of age, who had documented H. pylori infection, were randomized to receive either standard triple or sequential therapy. H. pylori eradication was ascertained using the C-13-urea breath test 4-6 weeks after the completion of the treatment. Real-time PCR was performed on gastric biopsy samples for assessment of CLA resistance. Results In all, 148 children (median age: 12.18 +/- 3.51 years) were recruited randomly into the study. The intention-to-treat eradication rates were 50% (37/74) for the sequential treatment group and 52.7% (39/74) for the standard triple treatment group (P = 0.87). A total of 136 children completed the study. The per-protocol eradication rates were 56% (37/66) and 55.7% (39/70) for sequential and standard triple therapy groups, respectively. CLA resistance was assessed and 113 children were included in the final analysis. Of 113 participants, 53 were in the sequential treatment group and 60 were in the standard triple treatment group. The success rates of the respective therapies (29/53 = 54.7% in sequential, 33/60 = 55% in standard therapy) were similar (P = 0.98). CLA resistance was detected in 29 (25.7%) of the patients. Eradication rates with sequential therapy in CLA susceptible and resistant cases were 60.5% (23/38) and 40% (6/15), respectively (P = 0.23). The corresponding figures for the standard triple treatment group were 63% (29/46) and 28.6% (4/14) (P = 0.033). Although a higher eradication rate was observed in CLA-resistant cases with sequential therapy, the difference did not reach statistical significance (P = 0.69). Conclusion In this study, standard triple treatment failed to eradicate H. pylori infection in the majority of the children, and sequential therapy offered only a small advantage over standard triple therapy in the eradication of CLA-resistant strains. (C) 2014 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
引用
收藏
页码:1202 / 1208
页数:7
相关论文
共 50 条
  • [31] Complete Genome Sequences of Helicobacter pylori Clarithromycin-Resistant Strains
    Tran Thanh Binh
    Suzuki, Rumiko
    Shiota, Seiji
    Kwon, Dong Hyeon
    Yamaoka, Yoshio
    GENOME ANNOUNCEMENTS, 2013, 1 (06)
  • [32] Standard Triple Therapy versus Sequential Therapy in Helicobacter pylori Eradication: A Double-Blind, Randomized, and Controlled Trial
    Eisig, Jaime Natan
    Navarro-Rodriguez, Tomas
    Sa Teixeira, Ana Cristina
    Silva, Fernando Marcuz
    Mattar, Rejane
    Chinzon, Decio
    Haro, Christiane
    Diniz, Marcio Augusto
    Moraes-Filho, Joaquim Prado
    Fass, Ronnie
    Barbuti, Ricardo Correa
    GASTROENTEROLOGY RESEARCH AND PRACTICE, 2015, 2015
  • [33] Sequential therapy versus standard triple-drug therapy for Helicobacter pylori eradication: Result of the HPFEZ randomised study
    Lahbabi, Mounia
    Alaoui, Samia
    El Rhazi, Karima
    El Abkari, Mohammed
    Nejjari, Chakib
    Amarti, Afaf
    Bennani, Bahia
    Mahmoud, Mustapha
    Ibrahimi, Adil
    Benajah, Dafr Allah
    CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2013, 37 (04) : 416 - 421
  • [34] Sequential Therapy Versus Standard Triple-Drug Therapy for Helicobacter pylori Eradication: a Systematic Review of Recent Evidence
    Kate, Vikram
    Kalayarasan, Raja
    Ananthakrishnan, Nilakantan
    DRUGS, 2013, 73 (08) : 815 - 824
  • [35] A randomized clinical trial; comparing levofloxacin based sequential and clarithromycin based sequential versus triple therapy for Helicobacter pylori eradication
    Moradniani, Mosayeb
    Firouzi, Majid
    Jaferian, Soleiman
    Shafizadeh, Shiva
    Baharvand, Parastoo
    Maleki, Hamed
    Beiranvand, Shahdokht Fathi
    Ghaderi, Nishtaman
    Sherkatolabbasieh, Hamidreza
    MEDICAL SCIENCE, 2018, 22 (90) : 134 - 139
  • [36] Sequential Therapy Versus Standard Triple-Drug Therapy for Helicobacter pylori Eradication: a Systematic Review of Recent Evidence
    Vikram Kate
    Raja Kalayarasan
    Nilakantan Ananthakrishnan
    Drugs, 2013, 73 : 815 - 824
  • [37] Eradication of Helicobacter pylori in Children by Triple Therapy Regimens of Amoxicillin, Omeprazole, and Clarithromycin or Azithromycin
    Esmaeili-Dooki, Mohammad Reza
    Shirdel, Hossein
    Hajiahmadi, Mahmood
    IRANIAN JOURNAL OF PEDIATRICS, 2015, 25 (06)
  • [38] COMPARISON OF CONCOMITANT QUADRUPLE THERAPY AND LEVOFLOXACIN-CONTAINING TRIPLE THERAPY FOR THE TREATMENT OF CLARITHROMYCIN-RESISTANT HELICOBACTER PYLORI INFECTION
    Kim, S.
    Choi, C.
    Kang, D.
    Kim, H.
    Park, S.
    Nam, H.
    Ryu, D.
    Kim, W.
    HELICOBACTER, 2015, 20 : 102 - 102
  • [39] Randomized Clinical Trial on the Efficacy of Triple Therapy Versus Sequential Therapy in Helicobacter pylori Eradication
    Sharif, Zain
    Mubashir, Muaz
    Naqvi, Mehdi
    Atique, Hassan
    Mahmood, Saira
    Ullah, Muneeb
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (05)
  • [40] Sequential therapy versus triple therapy for Helicobacter pylori eradication:: A randomized-controlled trial
    Vaira, Dino
    Zullo, Angelo
    Vakil, Nimish
    Gatta, Luigi
    Ricci, Chiara
    Perna, Federico
    Hassan, Cesale
    Tampien, Andrea
    Morini, Sergio
    GASTROENTEROLOGY, 2007, 132 (04) : A110 - A110